Jing Ma from San Francisco, CA, age 34

Lawyers & Attorneys

Jing Ma - Lawyer

view source

Specialties:

Commercial Transactions
Mergers and Acquisitions
Securities
Corporate Law
Arbitration
Litigation

ISLN:

918685122

Admitted:

2005

University:

Peking University, Beijing, China, B.A., 1996; Peking University, Beijing, China, B.A., 1996; Peking University, Beijing, China, M.A., 1999; Peking University, Beijing, China, M.A., 1999

Law School:

Boston University, J.D., 2004

Name / Title

Company / Classification

Phones & Addresses

Jing Ma
President

CELVAX, INC
Business Services at Non-Commercial Site · Nonclassifiable Establishments

12886 Ralston Cir, San Diego, CA 92130

Jing Ma
Director, President, Secretary, Treasurer

Bay Area Labs, Inc

34313 Gadwall Cmn, Fremont, CA 94555

Us Patents

Methods For Improvement Of Lung Function Using Tgf-Beta Inhibitors
view source
US Patent:

20040146509, Jul 29, 2004
Filed:

Jul 23, 2003
Appl. No.:

10/626004
Inventors:

Zhihe Li - Foster City CA, US
David Liu - Palo Alto CA, US
Jing Ma - Cupertino CA, US
Andrew Protter - Palo Alto CA, US
George Schreiner - Los Altos CA, US
International Classification:

A61K039/395
US Classification:

424/144100
Abstract:

The invention concerns methods for improvement of lung function by administering non-peptide small molecule inhibitors of TGF- specifically binding to the type I TGF- receptor (TGF-R1). Preferably, the inhibitors are quinazoline derivatives.

Preparation And Application Of Anti-Tumor Bifunctional Fusion Proteins
view source
US Patent:

20040254108, Dec 16, 2004
Filed:

Nov 26, 2003
Appl. No.:

10/723003
Inventors:

Jing Ma - San Diego CA, US
Yajun Guo - Shanghai, CN
International Classification:

A61K038/17
C07K014/705
US Classification:

514/012000, 530/350000, 536/023500, 435/069700, 435/320100, 435/325000
Abstract:

Provided herein is a chimeric protein, which chimeric protein comprises a Flt3 ligand, or a biologically active fragment thereof, and a proteinuous or peptidyl tumoricidal agent, and uses thereof, particularly in the treatment of malignancy.

Antibodies Specific For Cancer Associated Antigen Sm5-1 And Uses Thereof
view source
US Patent:

20050031617, Feb 10, 2005
Filed:

Nov 26, 2003
Appl. No.:

10/722849
Inventors:

Jing Ma - San Diego CA, US
Yajun Guo - Shanghai, CN
International Classification:

A61K039/395
C07K016/40
US Classification:

424146100, 530388260
Abstract:

The invention concerns antibodies which is specific for SM5-1 antigen expressed in melanoma, breast cancer and hepatocellular carcinoma, and polynucleotides encoding the antibodies. The invention further concerns use of such antibodies and/or polynucleotides in diagnosing and treating malignancies.

Nitrobenzyl Derivatives Of Anti-Cancer Agents
view source
US Patent:

20210017120, Jan 21, 2021
Filed:

Sep 29, 2020
Appl. No.:

17/036588
Inventors:

- Taipei City, TW
Yeyu Cao - South San Francisco CA, US
Xiaohong Cai - South San Francisco CA, US
Hailong Jiao - South San Francisco CA, US
Jing Yuan Ma - South San Francisco CA, US
Mark Matteucci - South San Francisco CA, US
Assignee:

OBI PHARMA, INC. - Taipei City
International Classification:

C07C 217/58
C07D 405/12
C07F 9/6558
A61K 47/64
C07D 403/06
A61K 47/55
A61P 35/00
C07D 239/94
C07D 487/04
C07D 471/04
C07C 213/02
C07D 491/22
C07H 19/06
Abstract:

Provided herein are compounds of formula I:wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Dna Alkylating Agents
view source
US Patent:

20190225633, Jul 25, 2019
Filed:

Mar 28, 2019
Appl. No.:

16/368753
Inventors:

- Taipei City, TW
Yeyu Cao - South San Francisco CA, US
Xiaohong Cai - South San Francisco CA, US
Hailong Jiao - South San Francisco CA, US
Jing Yuan Ma - South San Francisco CA, US
Mark Matteucci - South San Francisco CA, US
Assignee:

OBI PHARMA, INC. - Taipei City
International Classification:

C07F 9/24
G01N 33/574
A61K 31/396
Abstract:

Provided herein are compounds of formula I:wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

(R)- And (S)-1-(3-(3-N,N-Dimethylaminocarbonyl)Phenoxyl-4-Nitrophenyl)-1-Ethyl-N,N'-Bis (Ethylene)Phosphoramidate, Compositions And Methods For Their Use And Preparation
view source
US Patent:

20180258116, Sep 13, 2018
Filed:

Nov 15, 2016
Appl. No.:

15/752854
Inventors:

- Taipei City, TW
Yeyu Cao - South San Francisco CA, US
Xiaohong Cai - South San Francisco CA, US
Hailong Jiao - South San Francisco CA, US
Jing Yuan Ma - South San Francisco CA, US
Mark Matteucci - South San Francisco CA, US
Assignee:

OBI Pharma, Inc. - Taipei City
International Classification:

C07F 9/564
A61P 35/00
Abstract:

Provided herein are optically active compounds of the formulae (ii); and (III) and pharmaceutical compositions thereof. Also provided herein are processes of making these compounds and resolving the racemic mixture or the enrichment of same with in one of its enantiomers to provide (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate, and methods of treating cancer comprising administering such compounds.

Aziridine Containing Dna Alkylating Agents
view source
US Patent:

20180169064, Jun 21, 2018
Filed:

Jun 23, 2016
Appl. No.:

15/736285
Inventors:

- South San Francisco CA, US
Xiaohong Cai - South San Francisco CA, US
Yeyu Cao - South San Francisco CA, US
Hailong Jiao - South San Francisco CA, US
Jing Yuan Ma - South San Francisco CA, US
Jian-Xin Duan - South San Francisco CA, US
International Classification:

A61K 31/396
A61K 31/4168
A61K 31/4178
A61K 31/665
A61K 31/675
A61P 35/00
Abstract:

Provided herein are compounds of formula (I)-(VI), wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Nitrobenzyl Derivatives Of Anti-Cancer Agents
view source
US Patent:

20180086693, Mar 29, 2018
Filed:

Apr 1, 2016
Appl. No.:

15/563481
Inventors:

- Taipei City, TW
Yeyu Cao - South San Francisco CA, US
Xiaohong Cai - South San Francisco CA, US
Hailong Jiao - South San Francisco CA, US
Jing Yuan Ma - South San Francisco CA, US
Mark Matteucci - South San Francisco CA, US
Assignee:

OBI PHARMA, INC. - Taipei City
International Classification:

C07C 217/58
C07D 491/22
C07D 405/12
C07C 213/02
C07H 19/06
Abstract:

Provided herein are compounds of formula I, wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.